Research Papers

25 of 31 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H.
J Pediatr Hematol Oncol (Unknown)
Published: 2024
2/6 Transparent
Impact of Facility Dog and Certified Child Life Specialist Dyad on Children's Pain and Anxiety During Needlestick Proce…
Spikestein A; Musante J; Huang HH; Stojanowski M; Rode D; Pillai P; Crouch GD.
J Pediatr Hematol Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Vaccine Immunity in Children After Hematologic Cancer Treatment: A Retrospective Single-center Study.
Cetin M; Gumy-Pause F; Gualtieri R; Posfay-Barbe KM; Blanchard-Rohner G.
J Pediatr Hematol Oncol (Unknown)
Published: 2023
2/6 Transparent
Silencing Lnc-HES1-10 Inhibits Osteosarcoma Cells Proliferation, Invasive Ability, and Metastasis.
Zhu Y; Zhang C; Zhang C; Chen S; Jin Z.
J Pediatr Hematol Oncol (Unknown)
Published: 2023
2/6 Transparent
Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome.
Weiser A; Hengartner H; Kottke R; Grehten P; Toelle SP; Gerber NU; Grotzer MA; Guerreiro Stucklin AS.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Interaction of E2F3a and CASP8AP2 Regulates Histone Expression and Chemosensitivity of Leukemic Cells.
Jin FF; Wang CJ; Cui L; Liu FF; Wang KL; Li WJ; Li ZG.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratificat…
Xu J; Zhao L.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
2/6 Transparent
Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis.
Wang M; Li F; Zhang J; Lu C; Kong W.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
2/6 Transparent
First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewin…
Spasov NJ; Dombrowski F; Lode HN; Spasova M; Ivanova L; Mumdjiev I; Burnusuzov H; Siebert N.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Clinical Features and Prognostic Factors of Early Outcome in Pediatric Hemophagocytic Lymphohistiocytosis: A Retrospect…
Zhou YH; Han XR; Xia FQ; Poonit ND; Liu L.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
2/6 Transparent
In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies.
van Engelen N; Diets I; Bresters D; van den Bergen JC; Vrancken AFJE; Kuiper RP; Jongmans MCJ.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hemiplegic-Migraine-like Attacks as First Manifestation of Diffuse Leptomeningeal Glioneuronal Tumor: A Case Report.
Fetta A; Pruccoli J; Biasucci G; Parisi R; Toni F; Melchionda F; Cordelli DM.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
2/6 Transparent
Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Fra…
Ghafuri DL; Abdullahi SU; Dambatta AH; Galadanci J; Tabari MA; Bello-Manga H; Idris N; Inuwa H; Tijjani A; Suleiman AA; Jibir BW; Gambo S; Gambo AI; Khalifa Y; Haliru L; Abdulrasheed S; Zakari MA; Greene BC; Trevathan E; Jordan LC; Aliyu MH; Baumann AA; DeBaun MR.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Two Cases of Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Thioguanine Treatment for Acute Lymphoblastic…
Gruhn B; Brodt G; Mentzel HJ; Ernst J.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease: Description of…
Tas ML; Molenaar JJ; Peek AML; Lequin MH; Verdijk RM; de Krijger RR; Tytgat GAM; van Noesel MM.
J Pediatr Hematol Oncol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Multimodal Treatment of Children With Sacrococcygeal Yolk Sac Tumor: Retrospective Analysis of Clinicopathology Charact…
Zhu J; Chen H; Chen T; Zhen Z; Wang J; Sun F; Lu S; Huang J; Zhang Y; Sun X.
J Pediatr Hematol Oncol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A Homozygous Mutation in 5' Untranslated Region of TNFRSF11A Leading to Molecular Diagnosis of Osteopetrosis Coinherita…
Chen T; Sun J; Liu G; Yin C; Liu H; Qu L; Fang S; Shifra A; Gilad G.
J Pediatr Hematol Oncol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Paternal Smoking Before Conception and During Pregnancy Is Associated With an Increased Risk of Childhood Acute Lymphob…
Cao Y; Lu J; Lu J.
J Pediatr Hematol Oncol (Unknown)
Published: 2020
1/6 Transparent
Personalized Therapy for Generalized Lymphatic Anomaly/Gorham-Stout Disease With a Combination of Sunitinib and Taxol.
Rössler J; Saueressig U; Kayser G; von Winterfeld M; Klement GL.
J Pediatr Hematol Oncol (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Safety and Effectiveness of Micafungin in Japanese Pediatric Patients: Results of a Postmarketing Surveillance Study.
Kobayashi C; Hanadate T; Niwa T; Yoshiyasu T; So M; Matsui K.
J Pediatr Hematol Oncol (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Pediatric Medical Care System in China Has Significantly Reduced Abandonment of Acute Lymphoblastic Leukemia Treatment.
Zhou Q; Hong D; Lu J; Zheng D; Ashwani N; Hu S.
J Pediatr Hematol Oncol (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic m…
Madden LM; Ngwube AI; Shenoy S; Druley TE; Hayashi RJ.
J Pediatr Hematol Oncol (Unknown)
Published: 2015
1/6 Transparent
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.
Schmiegelow K; Nielsen SN; Frandsen TL; Nersting J.
J Pediatr Hematol Oncol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Characterization of localized osteosarcoma of the extremity in children, adolescents, and young adults from a single in…
Sugalski AJ; Jiwani A; Ketchum NS; Cornell J; Williams R; Heim-Hall J; Hung JY; Langevin AM.
J Pediatr Hematol Oncol (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refra…
Patel SA; Coulter DW; Grovas AC; Gordon BG; Harper JL; Warkentin PI; Wisecarver JL; Sanger WG; Coccia PF.
J Pediatr Hematol Oncol (Unknown)
Published: 2014
1/6 Transparent